Cargando…
Adjuvant chemotherapy or no adjuvant chemotherapy? A prediction model for the risk stratification of recurrence or metastasis of nasopharyngeal carcinoma combining MRI radiomics with clinical factors
BACKGROUND: Dose adjuvant chemotherapy (AC) should be offered in nasopharyngeal carcinoma (NPC) patients? Different guidelines provided the different recommendations. METHODS: In this retrospective study, a total of 140 patients were enrolled and followed for 3 years, with 24 clinical features being...
Autores principales: | Wu, Qiaoyuan, Chang, Yonghu, Yang, Cheng, Liu, Heng, Chen, Fang, Dong, Hui, Chen, Cheng, Luo, Qing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10522047/ https://www.ncbi.nlm.nih.gov/pubmed/37751422 http://dx.doi.org/10.1371/journal.pone.0287031 |
Ejemplares similares
-
IMRT combined with concurrent chemotherapy plus adjuvant chemotherapy versus IMRT combined with concurrent chemotherapy alone in patients with nasopharyngeal carcinoma
por: Zhong, Qiulu, et al.
Publicado: (2017) -
Adjuvant chemotherapy
por: Glimelius, B.
Publicado: (2013) -
The Current Role of Adjuvant Chemotherapy in Locally Advanced Nasopharyngeal Carcinoma
por: Su, Lin, et al.
Publicado: (2021) -
Treatment outcomes of induction chemotherapy combined with intensity-modulated radiotherapy and adjuvant chemotherapy for locoregionally advanced nasopharyngeal carcinoma in Southeast China
por: Wang, Peirong, et al.
Publicado: (2021) -
The Effects of Different Induction Chemotherapy Cycles and Adjuvant Chemotherapy on the Survival Outcomes of Patients With Locally Advanced Nasopharyngeal Carcinoma
por: Liao, Shu, et al.
Publicado: (2022)